# LSP1

## Overview
LSP1, or lymphocyte-specific protein 1, is a gene that encodes a cytoskeletal protein involved in the regulation of actin dynamics, cell adhesion, and migration. The LSP1 protein is predominantly expressed in leukocytes, such as T-cells, B-cells, macrophages, and neutrophils, as well as in endothelial cells, where it plays a critical role in cellular processes like lamellipodia formation and focal adhesion dynamics (Schäringer2020LSP1myosin1e). Structurally, LSP1 contains multiple F-actin binding domains, which facilitate its interaction with the cytoskeleton and contribute to its function in actomyosin contractility (Cervero2018Lymphocytespecific). The protein undergoes post-translational modifications, including phosphorylation by protein kinase C (PKC) and p38 MAPK, which modulate its activity and cellular localization (Hossain2013ICAM-1-mediated; Matsumoto1995Protein). LSP1 is implicated in various physiological and pathological processes, including immune cell migration, phagocytosis, and cancer metastasis, highlighting its significance in both normal cellular function and disease states (Qi2024CRISPRCas9based; JongstraBilen1992The).

## Structure
Lymphocyte-specific protein 1 (LSP1) is a cytoskeletal protein characterized by distinct structural domains. The protein consists of 330 amino acids, featuring an NH2-terminal acidic domain and a COOH-terminal basic domain. The COOH-terminal domain is highly conserved between mouse and human and is responsible for binding to F-actin, a component of the cytoskeleton (JongstraBilen1992The). This domain shares homology with the F-actin binding fragment of caldesmon, suggesting a conserved mechanism of action (JongstraBilen1992The).

LSP1 contains two caldesmon-like F-actin binding domains (C1, C2) and two villin-headpiece-like F-actin binding domains (V1, V2) (Cervero2018Lymphocytespecific). The C-terminal region is involved in recruiting myosin IIA and its regulators, such as myosin light chain kinase (MLCK) and calmodulin, indicating its role in actomyosin contractility (Cervero2018Lymphocytespecific).

Post-translational modifications of LSP1 include phosphorylation by protein kinase C (PKC), which influences its cellular localization and function (Matsumoto1995Protein). LSP1 also exists in multiple isoforms, which may result from alternative splicing or post-translational modifications, contributing to its functional diversity (Klein1989LymphocyteSpecific; Matsumoto1995Protein).

## Function
Lymphocyte-specific protein 1 (LSP1) is a cytoskeletal protein that plays a significant role in regulating actin cytoskeleton dynamics, cell adhesion, and migration. It is primarily expressed in leukocytes, including T-cells, B-cells, macrophages, and neutrophils, as well as in endothelial cells (Schäringer2020LSP1myosin1e). LSP1 interacts with F-actin through its COOH-terminal basic domain, which is crucial for its binding to the cytoskeleton and targeting within the cell (JongstraBilen1992The).

LSP1 is involved in the formation and dynamics of lamellipodia and focal adhesions, essential structures for cell migration. Its interaction with myosin1e forms a complex that is vital for efficient focal adhesion dynamics and lamellipodia formation (Schäringer2020LSP1myosin1e). This complex may activate signaling pathways for actin cytoskeleton remodeling, involving components like WASP and the Arp2/3 complex, which are crucial for actin filament nucleation and cell migration (Schäringer2020LSP1myosin1e).

In addition to its role in cell migration, LSP1 is implicated in cytoskeletal remodeling during processes such as phagocytosis and B-cell activation, where it associates with membrane immunoglobulin and enhances cell motility (JongstraBilen1992The). LSP1's function is regulated by phosphorylation, which affects its localization and interaction with the actin cytoskeleton (Schäringer2020LSP1myosin1e).

## Clinical Significance
Mutations and alterations in the expression of the LSP1 gene have been associated with various diseases, particularly in the context of cancer. In breast cancer, certain single nucleotide polymorphisms (SNPs) in LSP1, such as rs2271439, have been linked to a potential protective effect against the disease in familial cases, with an odds ratio (OR) of 0.73, suggesting a reduced risk (Hemminki2010Low‐risk). Another study found that the minor allele of SNP rs3817198 in LSP1 showed a trend towards association with positive lymph-node status in breast cancer, although this was not statistically significant (Huijts2007Clinical).

In ovarian cancer, LSP1 plays a significant role in metastasis. The FCGR1A gene, which regulates LSP1 expression, has been shown to promote epithelial-mesenchymal transition (EMT) in ovarian cancer cells, enhancing their migratory and invasive capabilities. This interaction suggests that LSP1 is crucial in the metastatic process, with its upregulation linked to increased cancer cell motility and poor prognosis (Qi2024CRISPRCas9based). The regulation of LSP1 by FCGR1A highlights its potential as a target for therapeutic intervention in ovarian cancer metastasis (Qi2024CRISPRCas9based).

## Interactions
LSP1 (lymphocyte specific protein 1) is known to interact with the cytoskeleton in leukocytes, where it binds to intracellular Ca2+ and F-actin. It serves as a substrate for protein kinase C (PKC) and p38 MAPK, indicating its involvement in signaling pathways that regulate leukocyte recruitment and microvascular permeability changes (Hossain2013ICAM-1-mediated). In endothelial cells, LSP1 is primarily located in the nucleus but also colocalizes with the cytoskeleton, suggesting a role in structural and signaling functions (Hossain2013ICAM-1-mediated).

The phosphorylation of endothelial LSP1 is primarily mediated by p38 MAPK signaling, as inhibition of p38 MAPK reduces LSP1 phosphorylation despite similar levels of neutrophil adhesion. This suggests that p38 MAPK plays a more significant role than PKC in LSP1 phosphorylation in this context (Hossain2013ICAM-1-mediated). LSP1 phosphorylation is linked to integrin-mediated adhesion processes, as blocking β2-integrins significantly reduces both neutrophil adhesion and LSP1 phosphorylation (Hossain2013ICAM-1-mediated). ICAM-1-mediated leukocyte adhesion is critical for the activation of endothelial LSP1, as blocking ICAM-1 reduces neutrophil adhesion and inhibits LSP1 phosphorylation (Hossain2013ICAM-1-mediated).


## References


[1. (JongstraBilen1992The) J Jongstra-Bilen, P A Janmey, J H Hartwig, S Galea, and J Jongstra. The lymphocyte-specific protein lsp1 binds to f-actin and to the cytoskeleton through its cooh-terminal basic domain. The Journal of cell biology, 118(6):1443–1453, September 1992. URL: http://dx.doi.org/10.1083/jcb.118.6.1443, doi:10.1083/jcb.118.6.1443. This article has 64 citations.](https://doi.org/10.1083/jcb.118.6.1443)

2. (Schäringer2020LSP1myosin1e) LSP1-myosin1e bi-molecular complex regulates focal adhesion dynamics and cell migration. This article has 0 citations.

[3. (Qi2024CRISPRCas9based) Yingying Qi, Weiyan Zhu, Kexin Mo, and Hui Jiang. Crispr/cas9-based genome-wide screening for metastasis ability identifies fcgr1a regulating the metastatic process of ovarian cancer by targeting lsp1. Journal of Cancer Research and Clinical Oncology, June 2024. URL: http://dx.doi.org/10.1007/s00432-024-05837-9, doi:10.1007/s00432-024-05837-9. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00432-024-05837-9)

[4. (Cervero2018Lymphocytespecific) Pasquale Cervero, Christiane Wiesner, Anais Bouissou, Renaud Poincloux, and Stefan Linder. Lymphocyte-specific protein 1 regulates mechanosensory oscillation of podosomes and actin isoform-based actomyosin symmetry breaking. Nature Communications, February 2018. URL: http://dx.doi.org/10.1038/s41467-018-02904-x, doi:10.1038/s41467-018-02904-x. This article has 49 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-018-02904-x)

[5. (Klein1989LymphocyteSpecific) D. P. Klein, J. Jongstra-Bilen, K. Ogryzlo, R. Chong, and J. Jongstra. Lymphocyte-specific ca2+-binding protein lsp1 is associated with the cytoplasmic face of the plasma membrane. Molecular and Cellular Biology, 9(7):3043–3048, July 1989. URL: http://dx.doi.org/10.1128/mcb.9.7.3043-3048.1989, doi:10.1128/mcb.9.7.3043-3048.1989. This article has 0 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.9.7.3043-3048.1989)

[6. (Hemminki2010Low‐risk) Kari Hemminki, Bertram Müller‐Myhsok, Peter Lichtner, Christoph Engel, Bowang Chen, Barbara Burwinkel, Asta Försti, Christian Sutter, Barbara Wappenschmidt, Heide Hellebrand, Thomas Illig, Norbert Arnold, Dieter Niederacher, Bernd Dworniczak, Helmut Deissler, Karin Kast, Dorothea Gadzicki, Thomas Meitinger, H.‐Erich Wichmann, Marion Kiechle, Claus R. Bartram, Rita K. Schmutzler, and Alfons Meindl. Low‐risk variants fgfr2, tnrc9 and lsp1 in german familial breast cancer patients. International Journal of Cancer, 126(12):2858–2862, April 2010. URL: http://dx.doi.org/10.1002/ijc.24986, doi:10.1002/ijc.24986. This article has 22 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/ijc.24986)

[7. (Huijts2007Clinical) Petra EA Huijts, Maaike PG Vreeswijk, Karin HG Kroeze-Jansema, Catharina E Jacobi, Caroline Seynaeve, Elly MM Krol-Warmerdam, Pauline M Wijers-Koster, Jannet C Blom, Karen A Pooley, Jan GM Klijn, Rob AEM Tollenaar, Peter Devilee, and Christi J van Asperen. Clinical correlates of low-risk variants in fgfr2, tnrc9, map3k1, lsp1 and 8q24 in a dutch cohort of incident breast cancer cases. Breast Cancer Research, November 2007. URL: http://dx.doi.org/10.1186/bcr1793, doi:10.1186/bcr1793. This article has 59 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1186/bcr1793)

[8. (Matsumoto1995Protein) Naoki Matsumoto, Somei Kojima, Toshiaki Osawa, and Satoshi Toyoshima. Protein kinase c phosphorylates p50 lsp1 and induces translocation of p50 lsp1 in t lymphocytes. The Journal of Biochemistry, 117(1):222–229, January 1995. URL: http://dx.doi.org/10.1093/OXFORDJOURNALS.JBCHEM.A124714, doi:10.1093/oxfordjournals.jbchem.a124714. This article has 29 citations.](https://doi.org/10.1093/OXFORDJOURNALS.JBCHEM.A124714)

[9. (Hossain2013ICAM-1-mediated) Mokarram Hossain, Syed M. Qadri, Yang Su, and Lixin Liu. Icam-1-mediated leukocyte adhesion is critical for the activation of endothelial lsp1. American Journal of Physiology-Cell Physiology, 304(9):C895–C904, May 2013. URL: http://dx.doi.org/10.1152/ajpcell.00297.2012, doi:10.1152/ajpcell.00297.2012. This article has 30 citations.](https://doi.org/10.1152/ajpcell.00297.2012)